We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$831M
AUM Growth
+$95.7M
Cap. Flow
-$18.2M
Cap. Flow %
-2.19%
Top 10 Hldgs %
37.16%
Holding
117
New
13
Increased
23
Reduced
36
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 84.63%
2 Industrials 2.17%
3 Technology 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCRA
26
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$12.1M 1.45%
381,579
+117,158
+44% +$4.15M
LJPC
27
DELISTED
La Jolla Pharmaceutical Company
LJPC
$11.3M 1.36%
1,759,171
ATRC icon
28
AtriCure
ATRC
$2.08B
$10.5M 1.27%
393,123
+37,395
+11% +$1.14M
RCM
29
DELISTED
R1 RCM Inc. Common Stock
RCM
$10.5M 1.26%
1,087,098
+16,600
+2% +$150K
BMY icon
30
Bristol-Myers Squibb
BMY
$129B
$10.4M 1.26%
218,697
-38,500
-15% -$1.92M
MDT icon
31
Medtronic
MDT
$112B
$9.47M 1.14%
103,951
-13,500
-11% -$1.21M
BSX icon
32
Boston Scientific
BSX
$68.4B
$9.28M 1.12%
241,876
PODD icon
33
Insulet
PODD
$11.8B
$8.64M 1.04%
90,860
-5,500
-6% -$471K
TNDM icon
34
Tandem Diabetes Care
TNDM
$1.27B
$8.62M 1.04%
135,667
-67,400
-33% -$3.54M
UNH icon
35
UnitedHealth
UNH
$382B
$8.53M 1.03%
34,488
-9,318
-21% -$2.38M
VRAY
36
DELISTED
ViewRay, Inc.
VRAY
$8.3M 1%
1,123,264
-77,300
-6% -$596K
OBSV
37
DELISTED
ObsEva SA Ordinary Shares
OBSV
$8.04M 0.97%
628,692
+64,000
+11% +$826K
ALBO
38
DELISTED
Albireo Pharma Inc
ALBO
$7.83M 0.94%
242,978
+13,000
+6% +$350K
ABT icon
39
Abbott
ABT
$188B
$7.8M 0.94%
97,598
STML
40
DELISTED
Stemline Therapeutics, Inc.
STML
$7.66M 0.92%
596,058
+557,220
+1,435% +$6.3M
FTSV
41
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$7.54M 0.91%
+466,502
New +$7.4M
HMSY
42
DELISTED
HMS Holdings Corp.
HMSY
$7.54M 0.91%
254,557
+242,160
+1,953% +$7.48M
BMRN icon
43
BioMarin Pharmaceuticals
BMRN
$11.9B
$7.13M 0.86%
80,321
-11,300
-12% -$1.05M
COGT icon
44
Cogent Biosciences
COGT
$6.76B
$6.97M 0.84%
396,859
+84,323
+27% +$1.44M
CBIO
45
Crescent Biopharma
CBIO
$546M
$6.83M 0.82%
+5,480
New +$6.27M
SVRA icon
46
Savara
SVRA
$1.08B
$6.61M 0.79%
896,200
+49,700
+6% +$374K
CI icon
47
Cigna
CI
$78.4B
$6.56M 0.79%
40,809
-26,310
-39% -$4.8M
ABMD
48
DELISTED
Abiomed Inc
ABMD
$6.41M 0.77%
22,427
IRTC icon
49
iRhythm Holdings
IRTC
$4.02B
$6.19M 0.74%
82,600
-14,800
-15% -$1.26M
ZBH icon
50
Zimmer Biomet
ZBH
$18.8B
$6.09M 0.73%
49,129
+46,967
+2,172% +$5.34M

Similar funds

Sectoral Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Sectoral Asset Management held 117 positions worth $831M, up 13% from $736M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sectoral Asset Management's Q1 2019 filing shows 13 new, 23 increased, 36 reduced and 11 closed positions. Its largest new stake was Shockwave Medical, Inc. Common Stock: 849,811 shares worth $28.4M. The largest sale was Array Biopharma Inc, an estimated $26.1M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 82% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q1 2019 buy was Shockwave Medical, Inc. Common Stock: 849,811 shares worth $28.4M.
  • Sectoral Asset Management added most to Assembly Biosciences in Q1 2019, an estimated $11.8M increase.
  • Sectoral Asset Management's biggest Q1 2019 reduction was Array Biopharma Inc, cutting an estimated $26.1M.
  • Sectoral Asset Management fully exited Immunomedics Inc in Q1 2019, selling an estimated $18.6M.
  • Sectoral Asset Management's ten largest holdings make up 37% of its $831M portfolio in Q1 2019.
  • Sectoral Asset Management opened 13 new positions and closed 11 in Q1 2019.
  • Sectoral Asset Management's portfolio value rose 13% quarter-over-quarter to $831M.

Based on Sectoral Asset Management's 13F filing for Q1 2019, filed 14 May 2019.